Differences in the absorption, metabolism and biliary excretion of a diastereomeric pair of ? v ? 3 - antagonists in rat: limited role of P-glycoprotein
- 1 January 2002
- journal article
- research article
- Published by Taylor & Francis in Xenobiotica
- Vol. 32 (3) , 207-220
- https://doi.org/10.1080/00498250110094403
Abstract
1. The study investigated mechanisms underlying the pharmacokinetic differences of two zwitterionic diastereomers ((3 S) -3-{ (3 R or 3 S) -2-oxo-3-[3-(5,6,7,8-tetrahydro-1,8- naphthyridin-2-yl)propyl]pyrrolidin-1-yl}-3-quinolin-3-ylpropanoic acid) with different lipophilicities using a combination of in vivo and in vitro approaches. 2. In rat, both isomers possessed comparable plasma clearances (CL). However, the more lipophilic diastereomer I exhibited a higher metabolic clearance (>2-fold higher than II), whereas the hydrophilic zwitterion II exhibited a higher biliary clearance (~5- fold higher than I) . Following oral administration, the bioavailability (F) of I (17%) was much higher than that of II (1%). 3. Consistent with these in vivo observations and the expectation based on their lipophilicity differences, the metabolism in rat liver microsomes was faster and the permeability in Caco-2 and LLC-PK1 cells and in situ rat intestinal loop was better for I than for II. 4.Only the absorption of the more lipophilic diastereomer I was subjected to an efflux system in the Caco-2 and in situ rat intestinal loop models. I was a good substrate for Pglycoprotein (P-gp) in both the human MDR1 and mouse mdr1a transfected cell lines, and in the wild-type mdr1a (+/+) mouse when compared with the P-gp-deficient mdr1a (-/-) mouse. Concomitant administration of I with verapamil in rat caused significant increases in oral AUC, F and C max of I without affecting its CL, further supporting the effect of P-gp in limiting the intestinal absorption of I in vivo in this animal model. 5. Since the findings that the lipophilic diastereomer I, but not II, was a good P-gp substrate were not in line with the observations that I was excreted to bile much slower than II and that I was absorbed better than II, the results suggested that P-gp played a minor role to the observed differences in the biliary excretion and intestinal absorption of the diastereomers I and II in rat.Keywords
This publication has 15 references indexed in Scilit:
- Identification and in vivo efficacy of small-molecule antagonists of integrin αvβ3 (the vitronectin receptor)Drug Discovery Today, 2000
- αvβ3 Integrin antagonists as inhibitors of bone resorptionExpert Opinion on Investigational Drugs, 2000
- Apparent lack of effect of P-glycoprotein on the gastrointestinal absorption of a substrate, tacrolimus, in normal mice.Pharmaceutical Research, 2000
- The Role of P-Glycoprotein and Canalicular Multispecific Organic Anion Transporter in the Hepatobiliary Excretion of DrugsJournal of Pharmaceutical Sciences, 1998
- Clinical Pharmacokinetics of IbuprofenClinical Pharmacokinetics, 1998
- Structure−Activity Relationship of Newly Synthesized Quinoline Derivatives for Reversal of Multidrug Resistance in CancerJournal of Medicinal Chemistry, 1997
- The Leukotriene LTD4 Receptor Antagonist Mk571 Specifically Modulates MRP Associated Multidrug ResistanceBiochemical and Biophysical Research Communications, 1995
- Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues.Proceedings of the National Academy of Sciences, 1987
- Noncompartmental Determination of the Steady‐State Volume of DistributionJournal of Pharmaceutical Sciences, 1979
- Intestinal Drug Absorption and Metabolism I: Comparison of Methods and Models to Study Physiological Factors of In Vitro and In Vivo Intestinal AbsorptionJournal of Pharmaceutical Sciences, 1970